Riskpilot← Back to searchSign inGet full accessKEBOMED OY
OYActiveY-tunnus 2391997-6Äyritie 12-AWholesale of pharmaceutical and medical goods · NACE 4646Est. 201111 employees
Revenue 2025
EUR 6,7M
+8% vs 2024
EBITDA margin
6.0%
-28% vs 2024
Equity ratio
84.6%
Financial strength
Net profit 2025
EUR 341K
-28% vs 2024
| Revenue | EUR 6,7M | +8% |
| EBITDA | EUR 399K | -28% |
| Net profit | EUR 341K | -28% |
| Total assets | EUR 4,4M | -6% |
| Equity | EUR 3,8M | +10% |
| Employees | 11 | — |
Legal name
KEBOMED OY
Y-tunnus number
2391997-6
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18. helmikuuta 2011
Share capital
EUR 2 500
Employees
11 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Bolagets verksamhetsområde är marknadsföring, försäljning och förmedling av medicinteknisk utrustning samt drivande av därmed förenlig verksamhet.
Address
Äyritie 12-A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 5 597 | 4 664 | 5 718 | 5 738 | 6 008 | 6 207 | 6 695 |
| Staff expenses | −831 | −847 | −884 | −957 | −1 019 | −1 135 | −1 230 |
| EBITDA | 884 | 425 | 1 107 | 816 | 680 | 555 | 399 |
| Depreciation & amort. | — | — | — | — | −0 | −0 | −0 |
| EBIT | 884 | 425 | 1 107 | 816 | 680 | 555 | 399 |
| Net financials | −9 | −1 | 1 | −1 | 30 | 42 | 29 |
| Profit before tax | 875 | 423 | 1 107 | 815 | 710 | 597 | 428 |
| Tax | 196 | 86 | 223 | 166 | 145 | 121 | 87 |
| Net profit | 679 | 337 | 884 | 648 | 565 | 476 | 341 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 1 097 | 1 334 | 2 331 | 2 948 | 4 305 | 4 721 | 4 448 |
| Equity | 510 | 847 | 1 731 | 2 380 | 2 945 | 3 421 | 3 762 |
| Long-term debt | — | — | — | — | 0 | 0 | 0 |
| Short-term debt | 587 | 487 | 600 | 568 | 1 360 | 1 300 | 686 |
| Total debt | 587 | 487 | 600 | 568 | 1 360 | 1 300 | 686 |
EBITDA margin
6.0%
This company
15.8%
Market median
-62% vs market
20192025
Equity ratio
84.6%
This company
38.2%
Market median
+121% vs market
20192025
Return on equity
9.1%
This company
18.4%
Market median
-51% vs market
20192025
Net profit margin
5.1%
This company
8.1%
Market median
-37% vs market
20192025
Asset turnover
1.51×
This company
1.12×
Market median
+35% vs market
20192025
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20192025
- Annual report 2025Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via PRH / YTJ · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via PRH / YTJ · Period 2018-07-01 – 2019-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JE Audit | Audit | 2021 | — | — |
KE Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
EP Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
MH Audit | Audit | 2013 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2016 | — | — | |
| Chairperson | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KEBOMED OY also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Juhani Eerik Loukusa | Audit | 0 companies |
| Kaj Erik Gussander | Chief Executive Officer | 0 companies |
| Eero Petteri Joenpolvi | Chief Executive Officer | 0 companies |
| Marika Helena Alho | Audit | 0 companies |
| Lars Lögstrup Poulsen | Board of Directors | 0 companies |
| Søren Dalmark Kornerup | Board of Directors | 0 companies |
| Jesper Siewers Möller | Board of Directors | 0 companies |
| Henrik Schjødt | Chairperson | 0 companies |